Financials

  • Market Capitalization 459.46 M
  • Employee 48
  • Founded 2020
  • CEO N/A
  • Website www.evommune.com
  • Headquarter Delaware, United States
  • FIGI BBG00Y79N887
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
2.4
ratio cours/chiffre d'affaires
2.05

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
2953
EDIT
Editas Medicine, Inc. - Common Stock
3.06 USD-3.16%-0.33%+18.60%+21.43%469.95 M USD
2959
RLMD
Relmada Therapeutics, Inc. - Common Stock
4.36 USD+0.69%-5.83%-17.11%+285.84%465.08 M USD
2972
CCCC
C4 Therapeutics, Inc. - Common Stock
3.71 USD-3.64%-9.73%+6.30%+44.36%456.42 M USD
2981
RZLT
Rezolute, Inc. - Common Stock
4.69 USD+1.52%-5.06%+3.30%-34.13%451.61 M USD